Article Versions Notes

Kawagishi N, Suda G, Yamamoto Y, Baba M, Furuya K, Maehara O, Ohnishi S, Yoshida S, Fu Q, Yang Z, et al. Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C. Viruses. 2023; 15(1):181. https://doi.org/10.3390/v15010181

Kawagishi, Naoki, Goki Suda, Yoshiya Yamamoto, Masaru Baba, Ken Furuya, Osamu Maehara, Shunsuke Ohnishi, Sonoe Yoshida, Qingjie Fu, Zijian Yang, and et al. 2023. "Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C" Viruses 15, no. 1: 181. https://doi.org/10.3390/v15010181

Kawagishi, N., Suda, G., Yamamoto, Y., Baba, M., Furuya, K., Maehara, O., Ohnishi, S., Yoshida, S., Fu, Q., Yang, Z., Hosoda, S., Tokuchi, Y., Kitagataya, T., Ohara, M., Suzuki, K., Nakai, M., Sho, T., Natsuizaka, M., Ogawa, K., & Sakamoto, N. (2023). Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C. Viruses, 15(1), 181. https://doi.org/10.3390/v15010181